EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gangliosides as Siglec ligands

Ronald L Schnaar iD

Glycoconjugate Journal · 2023-04 · 40 (2) · 159-167

DOI: 10.1007/s10719-023-10101-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Glycoconjugate Journal, online erschienen am 26.01.2023. Verfasst von Ronald L Schnaar. Beteiligte Einrichtung: Department of Pharmacology and Molecular Sciences, Department of Neuroscience, Johns Hopkins University School of Medicine, 725 N Wolfe St, Baltimore…. Hauptthemen laut MEDLINE: Sialic Acid Binding Immunoglobulin-like Lectins, Gangliosides. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The structure of a sialoglycan can be translated into to a biological response when it binds to a specific endogenous lectin. Among endogenous sialic acid-binding lectins in humans are those comprising the 15-member Siglec family, most of which are expressed on overlapping sets of immune cells. Endogenous Siglec ligands are sialoglycolipids (gangliosides) and/or sialoglycoproteins, on cell surfaces or in the extracellular milieu, that bind to and initiate signaling by cell surface Siglecs. In the nervous system, where gangliosides are the predominant sialoglycans, Siglec-4 (myelin-associated glycoprotein) on myelinating cells binds to gangliosides GD1a and GT1b on nerve cell axons to ensure stable and productive axon-myelin interactions. In the immune system, Siglec-7 on natural killer cells binds to gangliosides GD3 and GD2 to inhibit immune signaling. Expression of GD3 and GD2 on cancer cells can lead to tumor immune evasion. Siglec-1 (sialoadhesin, CD169) on macrophages binds to gangliosides on tumors and enveloped viruses. This may enhance antigen presentation in some cases, or increase viral distribution in others. Several other Siglecs bind to gangliosides in vitro, the biological significance of which has yet to be fully established. Gangliosides, which are found on all human cells and tissues in cell-specific distributions, are functional Siglec ligands with varied roles driving Siglec-mediated signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sialic Acid Binding Immunoglobulin-like LectinsGangliosidesHumansLigandsNeurons

Stichwörter der Autor:innen

CD33MacrophagesMyelin-associated glycoproteinNatural killer cellsSialic acidSialoadhesin

Substanzen

Sialic Acid Binding Immunoglobulin-like LectinsLigandsGangliosides

Autor:innen und Institutionen

  • Department of Pharmacology and Molecular Sciences, Department of Neuroscience, Johns Hopkins University School of Medicine, 725 N Wolfe St, Baltimore, MD, 21205, USA. schnaar@jhu.edu.

ORCID-Profile: Ronald L Schnaar

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Schnaar, R. L. (2023). Gangliosides as Siglec ligands. Glycoconjugate Journal, 40(2), 159-167. https://doi.org/10.1007/s10719-023-10101-2

Vancouver

Schnaar RL. Gangliosides as Siglec ligands. Glycoconjugate Journal. 2023;40(2):159-167. doi:10.1007/s10719-023-10101-2

BibTeX
@article{Schnaar2023,
  author = {Schnaar, Ronald L},
  title = {Gangliosides as Siglec ligands},
  journal = {Glycoconjugate Journal},
  year = {2023},
  volume = {40},
  number = {2},
  pages = {159--167},
  doi = {10.1007/s10719-023-10101-2}
}
Kostenlos starten →